US BIS CWCR Amendment: Schedule 2A Mixture Concentration Reporting Threshold Reduced to 10%

Mechanism

Prior to this rule, US persons were required to submit declarations and report exports/imports of mixtures containing a Schedule 2A chemical only when the Schedule 2A constituent was present at 30% or more by weight or volume. BIS reduced that threshold to 10% to implement a 2009 OPCW multilateral decision (C-14/DEC.4) that lowered the harmonised declaration threshold for all OPCW States Parties.

The 10% floor is hardcoded in the Chemical Weapons Convention Implementation Act (CWCIA); BIS cannot go lower without a statutory change. Schedule 2B chemicals (a separate sub-list) remain at the 30% threshold and are unaffected.

Affected Schedule 2A chemicals:

Affected facilities must now file Form BIS-748P declarations when any of these three chemicals appears at ≥10% concentration in a mixture that is manufactured, processed, consumed, exported, or imported. Annual facility reports to the National Authority (BIS) are also subject to the lower threshold.

Downstream implications

• Fluoromonomer and PTFE producers that generate PFIB as a byproduct at concentrations

between 10–30% are newly brought into the CWCR declaration regime.

• Defence contractors handling Amiton or BZ formulations face additional annual

reporting burdens; most will already comply under ITAR, but the parallel CWCR obligations now capture lower-concentration mixes.

• No trade flow restrictions result from this rule — it is a reporting/declaration

amendment only, not a licensing prohibition or export ban.

• The long delay between the 2009 OPCW decision and this 2023 US implementation

reflects the administrative pace of US CWC-implementing rulemaking; other OPCW States Parties implemented C-14/DEC.4 much earlier.

Open questions

• Whether BIS will separately update CWCR to implement later OPCW CSP decisions

(e.g., Schedule 1 additions post-Salisbury poisoning — novichok agents added 2019).

• PFIB's status as an industrial byproduct rather than a manufactured CW precursor

raises ongoing compliance questions for fluorochemical producers about routine process-stream characterisation.